EPISODE · Jul 17, 2026 · 46 MIN
#1 Monthly. Peptides, FDA Approval & Longevity Trends: Dr. Myles Spar Separates Science From Hype
from The Living Room Podcast · host Chris Wharton
The peptide space is exploding. Claims are everywhere. But for most peptides, the human evidence is still surprisingly limited.Dr. Myles Spar is a board-certified Internal Medicine physician, Integrative Medicine physician, and Clinical Translator at The WNDR Lab. He has spent his career helping translate longevity science into practical medicine, and in this conversation, he breaks down one of the most talked-about topics in health today: peptide therapy.From BPC-157 and TB-500 to MOTS-c and GHK Copper, Dr. Spar explains why the excitement has outpaced the evidence, what the FDA's proposed recategorization of certain peptides actually means (and what it doesn't), and how to evaluate health claims before putting anything in your body.The conversation also explores how to separate evidence from hype, why correlation isn't causation, and why the fundamentals of health still outperform any shortcut.This episode also marks the launch of a new recurring series: The Truth Behind the Trend” on The LIVING Room Podcast. In this series, Chris Wharton sits down with leading experts in their fields to examine what's making the news, what the science says, and what it actually means for your health. These shorter conversations are designed to help you think more critically, ask better questions, and separate evidence from hype. What we cover in this episode:Why most peptide research is still limited—and why that mattersBPC-157, TB-500, MOTS-c, and GHK Copper: what we know todayWhat the FDA's proposed peptide recategorization means—and why it does not mean FDA approvalThe difference between FDA-approved, FDA-cleared, and compounded productsWhy injectable peptides have more evidence behind them than patches, creams, and sublingual formulationsThe risks of buying peptides from unregulated sourcesWhy therapeutic plasma exchange may be overhyped in longevity medicineThe "proof commensurate with harm" principle for evaluating health interventionsWhy correlation does not equal causation in health researchHow to run your own N-of-1 experiment to determine what actually works for youWhy exercise, sleep, nutrition, stress management, and other fundamentals remain the foundation of longevityIf you're trying to make sense of the rapidly growing world of peptides, biohacking, and longevity medicine, this episode offers a practical, evidence-based framework for thinking critically about the latest health trends.Want more? Each month, we send a newsletter curated by our scientific council on what's actually advancing the science of human longevity — and what isn't. Subscribe at https://www.thewndrlab.com/mailing-list. Connect with Dr. Myles Spar:Instagram: https://www.instagram.com/drspar/ LinkedIn: https://www.linkedin.com/in/drspar/ Connect with our host Chris Wharton on Instagram: https://www.instagram.com/chriswharton1 Follow The LIVING Room Podcast on Socials:Instagram: https://www.instagram.com/the.living.room.pod/LinkedIn: linkedin.com/company/wndrlab/The WNDR Lab: https://www.thewndrlab.com/
Embed this episode
What this episode covers
The peptide space is exploding. Claims are everywhere. But for most peptides, the human evidence is still surprisingly limited. Dr. Myles Spar is a board-certified Internal Medicine physician, Integrative Medicine physician, and Clinical Translator at The WNDR Lab. He has spent his career helping translate longevity science into practical medicine, and in this conversation, he breaks down one of the most talked-about topics in health today: peptide therapy. From BPC-157 and TB-500 to MOTS-c a...
Ready to play
#1 Monthly. Peptides, FDA Approval & Longevity Trends: Dr. Myles Spar Separates Science From Hype
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.